ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO
NEW YORK, NY / ACCESS Newswire / March 11, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Soleno Therapeutics, Inc. (NASDAQ:SLNO) between March 26, 2025 through November 4, 2025, both dates inclusive (the "Class Period"). A class action […]